Parkinson's disease is a widely recognized condition, but there's another disorder with similar early symptoms that your doctor might initially miss. If you've noticed your balance shifting ...
- Topline supports moving to Phase 3 trial and shows potential to develop GV1001 as the world's first PSP treatment PSP is a degenerative disease that, like Parkinson's disease, causes symptoms such ...
This is a randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy, safety, and pharmacokinetics of FNP-223 (oral formulation) in slowing the progression ...
LILLE, France--(BUSINESS WIRE)--Alzprotect, a French biopharmaceutical company, is pleased to announce the successful completion of the open-label extension (OLE) phase following the Phase 2a clinical ...
Hosted on MSN
Progressive supranuclear palsy and how awareness of the disease can move toward more therapies
The Rainbow Coalition announced this week that civil rights icon and Greenville native, the Rev. Jesse Jackson, has been hospitalized and is under observation for progressive supranuclear palsy, or ...
BARCELONA, Spain--(BUSINESS WIRE)--Ferrer, a B Corp-certified international pharmaceutical company, has announced the dosing of the first participant in the Phase II clinical trial, PROSPER. The study ...
A clinical trial that will test three drugs concurrently, and could include more, represents new hope for patients with progressive supranuclear palsy (PSP), an incurable neurodegenerative disorder ...
Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are sporadic four-repeat tauopathies that have characteristic clinical and neuropathologic profiles, but also share overlapping ...
Milton Keynes Citizen on MSN
Free Neuro-orthoptics in Progressive Supranuclear Palsy masterclass
The UK charity, PSPA, which has its head office in Milton Keynes, is hosting a free online masterclass on 25 March to help ophthalmic professionals understand Progressive Supranuclear Palsy (PSP) and ...
These findings indicate that PSP pathology affects gait control pathways that are also affected in PD. Gait changes associated with defective scaling of stride length and postural instability were ...
Explore why tau still lacks treatments despite its critical role in Alzheimer's disease and other tauopathies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results